AstraZeneca PLC

AZN 
(NasdaqOMXS) 
 

Company Profile

Description
AstraZeneca (AZ) is a global prescription-based biopharmaceutical company. AZ uses its focus on drugs and biologics to create innovative, large revenue pharmaceuticals. The industry and AZ has faced deteriorating R&D productivity, but AZ has streamlined its R&D activity and is depending on external research and in-licensing to bolster the development of new products. AZ is reliant on its strong growth from emerging and less penetrated markets to offset its underperforming and declining sales from the US and Western Europe.
Key Stats
Website:
Headquarter country:
Employees: 0
Market Cap (at close ):
Fiscal Year Ends:

Stats



Price/Earnings
Forward Price/Earnings
Price/Free Cash Flow
Return of Assets
Return on Equity
Return on Invested Capital
20182017201620152014

Dividend


Dividend/Share
Ex. Dividend Date
Trailing Dividend Yield
Payout Ratio





Date Currency Amount

Income Statement DKK



Revenue
Total Revenue
Gross Profit
Gross Margin %
EBITDA
Net Income
Basic Earnings Per Share

Operating Expenses
Operating Income
Operation Margin %
20182017201620152014


Cash Flow DKK



Operating Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow
20182017201620152014


Balance Sheet DKK



Assets
Current Assets
Long Term Assets
Total Assets

Liabilities
Total Current Liabilities
Long Term Liabilities
Total Liabilities

Equity
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets
31/12/201831/12/201731/12/201631/12/201531/12/2014



Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 June 2019 12:55:53
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB6 - 2019-06-19 13:55:53 - 2019-06-19 12:55:53 - 1000 - Website: OKAY